DPP-IV Inhibition Prior to Development of Diabetes in Patients With Cystic Fibrosis

Trial Profile

DPP-IV Inhibition Prior to Development of Diabetes in Patients With Cystic Fibrosis

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Saxagliptin (Primary)
  • Indications Diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Apr 2015 Planned initiation date changed from 1 Oct 2014 to 1 Jun 2015, according to ClinicalTrials.gov record.
    • 16 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top